Abstract
Permanent pacemakers, implantable cardioverter defibrillators (ICDs) and cardiac resynchronization (CRT) devices are commonly used in the management of cardiovascular disease. Sick sinus syndrome and atrio-ventricular block are the two most common indications for permanent pacemaker implantation, representing more than 90% of the cases, and are both strongly associated with increasing age. Understanding the cardiovascular physiology among elderly patients is critical to the selection of the optimal surgical technique and reduction of complications. In this chapter, the role of pacemakers, ICDs, CRTs as well as technical issues for cardiac rhythm device implantation, including risk of device-related complications and appropriate programming in elderly patients, is discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Healey JS, Toff WD, Lamas GA, et al. Cardiovascular outcomes with atrial-based pacing compared with ventricular pacing: meta-analysis of randomized trials, using individual patient data. Circulation. 2006;114(1):11–7.
Bristow MR, Saxon LA, Boehmer J, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350:2140–50.
Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346(12):877–83.
Cleland JG, Daubert J-C, Erdmann E, et al. The effect of cardiac resynchronization on morbidity and mortalilty in heart failure. N Engl J Med. 2005;352:1539–49.
Curtis JP, Rathore SS, Wang Y, et al. The association of 6-minute walk performance and outcomes in stable outpatients with heart failure. J Card Fail. 2004;10:9–14.
Aggarwal A, Wang Y, Rumsfeld JS, Curtis JP, Heidenreich PA. Clinical characteristics and in-hospital outcome of patients with end-stage renal disease on dialysis referred for implantable cardioverter defibrillator implantation. Heart Rhythm. 2009;6(11): 1565–71.
Bernstein AD, Parsonnet V. Survey of cardiac pacing and defibrillation in the United States in 1993. Am J Cardiol. 1996;78:187–96.
Kozak LJ, Owings MF, Hall MJ. National Hospital Discharge Survey: 2002 annual summary with detailed diagnosis and procedure data. Vital Health Stat. 2005;13(158):1–199.
Healey J, Connolly SJ, Morillo CA. The management of patients with carotid sinus hypersensitivity: is pacing the answer? Clin Auton Res. 2004;14 Suppl 1:80–6.
McIntosh S, da Costa D, Kenny RA. Benefits of an integrated approach to the investigation of dizziness, falls and syncope in the elderly. Age Ageing. 1993;22:53–8.
Lamas GA, Orav J, Stambler BS, et al. Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual-chamber pacing. N Engl J Med. 1998;338:1097–104.
Toff WD, Camm AJ, Skehan JD. Single-chamber versus dual-chamber pacing for high-grade atrioventricular block. N Engl J Med. 2005;353(2):145–55.
Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225–37.
Huang DT, Sesselberg HW, McNItt S, et al. Improved survival associated with prophylactic implantable defibrillators in elderly patients with prior myocardial infarction and depressed ventricular function: a MADIT-II substudy. J Cardiovasc Electrophysiol. 2007;18(8):833–8.
Peterson PN, Daugherty SL, Wang Y, et al. Gender differences in procedure-related adverse events in patients receiving implantable cardioverter-defibrillator therapy. Circulation. 2009;119(8):1078–84.
Bradley DJ, Bradley EA, Baughman KL, et al. Cardiac resynchronization and death from progressive heart failure: a meta-analysis of randomized controlled trials. JAMA. 2003;289:730–40.
Birnie D, Wiliams K, Guo A, et al. Reasons for escalating pacemaker implants. Am J Cardiol. 2006;98(1):93–7.
Shen WK, Hammill SC, Hayes DL, et al. Long-term survival after pacemaker implantation for heart block in patients >65 years. Am J Cardiol. 1994;74(6):560–4.
Sutton R, Chatterjee K, Leatham A. Heart-block following acute myocardial infarction. Treatment with demand and fixed-rate pacemakers. Lancet. 1968;2(7569):645–8.
Alpert MA, Curtis JJ, Sanfelippo JF, et al. Comparative survival after permanent ventricular and dual chamber pacing for patients with chronic high degree atrioventricular block with and without pre-existing congestive heart failure. J Am Coll Cardiol. 1986;7:925–32.
Shen WK, Hayes DL, Hammill SC, Bailey KR, Ballard DJ, Gersh BJ. Survival and functional independence after implantation of a permanent pacemaker in octogenarians and nonagenarians. A population-based study. Ann Intern Med. 1996;125(6):476–80.
Lipsitz LA, Wei JY, Rowe JW. Syncope in elderly, institutionalized population: prevalence, incidence and associated risk. Q J Med. 1985;55:45–55.
Hale WA, Delaney MJ, McGaghie WC. Characteristics and predictors of falls in elderly patients. J Fam Pract. 1992;34:577–81.
O¢Laughlin JL, Robitaille Y, Boivin JF, Suissa S. Incidence and risk factors for falls and injurious falls among the community-dwelling elderly. Am J Epidemiol. 1993;137:342–5.
Parry SW, Baptist M, Kenny R-A. Drop attacks in older adults: systematic assesment has high diagnostic yield. J Am Geriatr Soc. 2005;53:74–8.
McIntosh SJ, Lawson J, Kenny RA. Clinical characteristics of vasodepressor, cardioinhibitory and mixed carotid sinus syndrome in the elderly. Am J Med. 1993;95:203–8.
Crilley JG, Herd B, Khurana CS, et al. Permanent cardiac pacing in elderly patients with recurrent falls, dizziness and syncope and a hypersensitive cardioinhibitory reflex. Postgrad Med J. 1997;73: 415–8.
Davies AJ, Kenny RA. Falls presenting to the accident and emergency department: types of presentation and risk factor profile. Ageing. 1996;25:362–5.
Parry SW, Richardson D, O'Shea D, et al. Diagnosis of carotid hypersensitivity in older adults: carotid sinus massage in the upright position is essential. Heart. 2000;83:22–3.
Parry SW, Steen IN, Baptist M, et al. Amnesia for loss of consciousness in patients with carotid sinus syndrome. J Am Coll Cardiol. 2005;45:1840–3.
Kenny RA, Richardson DA, Steen N, et al. Carotid sinus syndrome: a modifiable risk factor for non-accidental falls in older adults (SAFE PACE). J Am Coll Cardiol. 2001;38:1491–6.
Richardson DA, Bexton RS, Shaw FE, Kenny R-A. Prevalence of cardio-inhibitory carotid sinus hypersensitivity in patients 50 years or over presenting to the accident and emergency department with “unexplained” or “recurrent” falls. Pacing Clin Electrophysiol. 1997;3(2):820–3.
Morley CA, Perrins EJ, Grant P, et al. Carotid sinus syncope treated by pacing. Analysis of persistent symptoms and role of atrioventricular sequential pacing. Br Heart J. 1982;47:411–8.
Fitzpatrick A, Theodorakis G, Ahmed R, Williams T, Sutton R. Dual chamber pacing aborts vasovagal syncope induced by head-up tilt. Pacing Clin Electrophysiol. 1991;4:13–9.
Brignole M, Menozzi C, Lolli G, Oddone D, Gianfranchi L, Bertulla A. Validation of a method of pacing mode in carotid sinus syndrome with or without sinus bradycardia. Pacing Clin Electrophysiol. 1991;14:196–203.
Brignole M, Menozzi C, Lolli G, Bottoni N, Gagglioli G. Long-term outcome of paced and nonpaced patients with severe carotid sinus syndrome. Am J Cardiol. 1992;69:1039–43.
McAnulty J. Carotid sinus massage in patients who fall: will it define the role of pacing? J Am Coll Cardiol. 2001;38:1497.
Parry SW, Steen N, Bexton RS, Tynan M, Kenny R-A. Pacing in elderly recurrent fallers with carotid sinus hypersenstivity: a randomised, double-blind, placebo controlled crossover trial. Heart. 2009;95(5):405–9.
Sheldon R. Components of clinical trials for vasovagal syncope. Europace. 2001;3:233–40.
Connolly SJ, Sheldon R, Roberts RS, Gent M. The North American vasovagal pacemaker study (VPS): a randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope. J Am Coll Cardiol. 1999;33(1):16–20.
Connolly SJ, Sheldon R, Thorpe KE, et al. Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope: second vasovagal pacemaker study (VPS II): a randomized trial. JAMA. 2003;289(17):2224–9.
Ammirati F, Colivicchi F, Santini M. Permanent cardiac pacing versus medical treatment for the prevention of recurrent vasovagal syncope: a multi-centre, randomized-controlled trial. Circulation. 2001;104:52–7.
Sutton R, Brignole M, Menozzi C, et al. The vasovagal syncope international study (VASIS) investigators. Dual-chamber pacing in the treatment of neurally mediated tilt-positive cardioinhibitory syncope: pacemaker versus no therapy: a multi-centre randomized study. Circulation. 2000;102:294–9.
Raviele A, Giada F, Menozzi C, et al. A randomized, double-blind, placebo-controlled study of permanent cardiac pacing for the treatment of recurrent tilt-induce vasovagal syncope. The vasovagal syncope and pacing trial (SYNPACE). Eur Heart J. 2004;25:1741–8.
Aggarwal RK, Connelly DT, Ray SG, Ball J, Charles RB. Early complications of permanent pacemaker implantation: no difference between dual and single chamber systems. Br Heart J. 1995;73: 571–5.
Chauhan A, Grace AA, Newell SA, et al. Early complications after dual-chamber versus single chamber pacemaker implantation. Pacing Clin Electrophysiol. 1994;17:2012–5.
Lee DS, Birinie D, Cameron D, et al. Design and implementation of a population-based registry of implantable cardioverter defibrillators (ICDs) in Ontario. Heart Rhythm. 2008;5(9):1250–6.
Curtis JP, Leubbert JJ, Wang Y, et al. Association of physician certification and outcomes among patients receiving an implantable cardioverter-defibrillator. JAMA. 2009;301(16):1661–70.
Pickett 3rd RA, Saavedra P, Ali MF, Darbar D, Rottman JN. Implantable cardioverter-defibrillator malfunction due to mechanical failure of the header connection. J Cardiovasc Electrophysiol. 2004;15(9):1095–9.
Gillis AM, MacQuarrie DS, Wilson SL. The impact of pulse generator longevity on the long-term costs of cardiac pacing. Pacing Clin Electrophysiol. 1996;19:1459–68.
Rusanov A, Spotnitz HM. A 15-year experience with permanent pacemaker and defibrillator lead and patch extractions. Ann Thorac Surg. 2010;89(1):44–50.
Mahapatra S, Bybee KA, Bunch TJ, et al. Incidence and predictors of cardiac perforation after permanent pacemaker placement. Heart Rhythm. 2005;2(9):907–11.
Connolly SJ, Hallstrom AP, Cappato R, et al. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. Eur Heart J. 2000;21:2071–8.
Sanders GD, Hlatky MA, Owens DK. Cost-effectiveness of implantable cardioverter-defibrillators. N Engl J Med. 2005;353:1471–80.
Mark DB, Anstrom KJ, Sun JL, et al. Quality of life with defibrillator therapy or amiodarone in heart failure. N Engl J Med. 2008;359(10):1058–9.
Poole JE, Johnson GW, Hellkamp AS, et al. Prognostic importance of defibrillator shocks in the sudden cardiac death in heart failure trial. N Engl J Med. 2008;359:1009–17.
Healey JS, Hallstrom AP, Kuck KH, et al. Role of the implantable defibrillator in elderly patients with a history of life-threatening ventricular arrhythmias. Eur Heart J. 2008;28(14):174–1749.
Krahn A, Connolly SJ, Roberts RS, Gent M, ATMA Investigators. Diminishing proportional risk of sudden death with advancing age: implications for prevention of sudden death. Am Heart J. 2004;147(5):837–40.
Duray G, Richter S, Manegold J, Israel CW, Gronefeld G, Hohnloser SH. Efficacy and safety of ICD therapy in a population of elderly patients treated with optimal background medication. J Interv Card Electrophysiol. 2005;14:169–73.
Kleman JM, Pinski SL, Morant VA. ICDs in the very elderly: short and long-term outcome. Pacing Clin Electrophysiol. 1994;17:835.
Noseworthy PA, Lashevsky I, Dorian P, Greene M, Cvitkovic S, Newman D. Feasibility of implantable cardioverter-defibrillator use in elderly patients. Pacing Clin Electrophysiol. 2004;27:373–8.
Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. Prevalence, age distribution and gender of patients with atrial fibrillation: analysis and implications. Arch Intern Med. 1995;155:469–73.
Baranchuk A, Healey JS, Thorpe KE, et al. The effect of atrial-based pacing on exercise capacity as measured by the 6-minute walk test: a sub-study of the Canadian trial of physiologic pacing (CTOPP). Heart Rhythm. 2007;4(8):1024–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Armaganijan, L., Healey, J.S. (2011). Pacemakers and Implantable Cardioverter Defibrillators in the Elderly. In: Katlic, M. (eds) Cardiothoracic Surgery in the Elderly. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-0892-6_35
Download citation
DOI: https://doi.org/10.1007/978-1-4419-0892-6_35
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-0891-9
Online ISBN: 978-1-4419-0892-6
eBook Packages: MedicineMedicine (R0)